Tous les communiqués | WebDisclosure

Switch to English

10382	Sociétés
216568	Mots-clés
146260	Articles
114661	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 07:15, il y a 1 année 10 mois

Inside Information / Other news releases
Eurofins provides update to key stakeholders on actions responding to Muddy Waters' reports and plans for related party transactions. Additionally, the company addresses cash accounting and corporate governance

Corporate Governance Muddy Waters Related Party Transactions Stakeholders Eurofins
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 07:05, il y a 1 année 10 mois

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation

Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
COMMUNIQUÉ RÉGLEMENTÉ

publié le 11/07/2024 à 07:01, il y a 1 année 10 mois

Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
Biophytis obtient l'autorisation IND de la FDA pour lancer l'étude OBA de phase 2 dans l'obésité avec BIO101 (20-hydroxyecdysone), visant à améliorer la force musculaire. Le professeur Marc-André Cornier dirigera l'étude multicentrique aux Etats-Unis

Biophytis BIO101 Obésité Autorisation IND Étude OBA
COMMUNIQUÉ RÉGLEMENTÉ

publié le 11/07/2024 à 07:01, il y a 1 année 10 mois

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 07:00, il y a 1 année 10 mois

Gerresheimer remains on track in 1st half year 2024
Gerresheimer remains on track with 1.7% revenue growth and 2.9% EBITDA increase in the 1st half of 2024. Plastics & Devices division shows good revenue growth and improved margin. Forecast for 2024 and 2025 confirmed

EBITDA Revenue Growth Forecast Gerresheimer 1st Half Year 2024
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 06:58, il y a 1 année 10 mois

DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base

Revenue Market Share DocMorris ERx Growth CardLink
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 03:00, il y a 1 année 10 mois

Charting the Future of Nutrition: Mission Hill Foods Expands Research and Strengthens Market Presence in North America
Mission Hill Foods invests in advanced research, dev, & sustainable practices for consumer health, expanding its capabilities & initiatives in North America

North America Research Development Sustainable Practices Mission Hill Foods
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 01:55, il y a 1 année 10 mois

Organto Provides Bi-Weekly Update on Filing of 2023 Annual Financial Statements and Status of MCTO
Organto Foods Inc. provides update on management cease trade order for late filing of annual financial statements. Company and auditors working to complete filings

Business Update Management Cease Trade Order Annual Financial Statements Organto Foods Inc. Organic Products
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 01:19, il y a 1 année 10 mois

Final Bell Holdings International Announces Revocation of Cease Trade Order and Closing of First Tranche of a US$12,000,000 Note Financing
Final Bell Holdings International Ltd. lifts cease trade order and closes first tranche of US$12 million convertible notes offering through subsidiary FBI for expansion in the United States

Expansion Final Bell Holdings International Ltd. Cease Trade Order Convertible Notes Offering FBI
COMMUNIQUÉ DE PRESSE

publié le 11/07/2024 à 00:00, il y a 1 année 10 mois

Mission Hill Highlights Advanced Formulations for Modern Health Needs, Focusing on Women's Health
Mission Hill Foods introduces premium products targeting gut health, heart health, vision protection, and immune support. Focus on women's health, product quality, sustainability, and innovative research projects

Innovation Women's Health Gut Health Mission Hill Foods Premium Products

Les Echos

Publié le 11/05/2026 à 19:02, il y a 10 heures 16 minutes

260511 BENETEAU Transactions sur actions propres
Publié le 11/05/2026 à 18:18, il y a 11 heures

Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Publié le 11/05/2026 à 18:18, il y a 11 heures

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Publié le 11/05/2026 à 18:14, il y a 11 heures 4 minutes

Nombre total d'actions et droits de vote - avril 2026
Publié le 11/05/2026 à 18:14, il y a 11 heures 4 minutes

Number of shares and voting rights - April 2026 (In French only)

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 12/05/2026 à 04:20, il y a 58 minutes

AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Publié le 12/05/2026 à 03:05, il y a 2 heures 13 minutes

UraniumX Reports Tragic Incident at Its Zoo Bay Property
Publié le 12/05/2026 à 00:00, il y a 5 heures 18 minutes

PPX Mining Provides Update on Start-up of the Process Plant
Publié le 12/05/2026 à 00:00, il y a 5 heures 18 minutes

Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Publié le 11/05/2026 à 23:00, il y a 6 heures 18 minutes

Revolve to Present at the 16th Annual LD Micro Invitational on May 18, 2026

Voir tout ACCESSWIRE

EQS Group

Publié le 12/05/2026 à 01:10, il y a 4 heures 8 minutes

Monport Brings Advanced Laser Machine With The New Mega S and UV Laser Technology in Germany
Publié le 12/05/2026 à 00:19, il y a 4 heures 59 minutes

EQS-Adhoc: ABO Energy GmbH & Co. KGaA adjusts its forecast for 2026 and complies with the obligation to report losses pursuant to Section 92 of Stock Corporation Act (AktG) – Draft restructuring report submitted
Publié le 11/05/2026 à 22:05, il y a 7 heures 13 minutes

Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Publié le 11/05/2026 à 22:05, il y a 7 heures 13 minutes

Abivax Announces Results of its May 11, 2026 Annual General Meeting
Publié le 11/05/2026 à 21:16, il y a 8 heures 2 minutes

Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy